Attached files

file filename
EX-2.1 - EXHIBIT 2.1+ - SPECTRUM PHARMACEUTICALS INClicenseamendroyaltyreducti.htm
EX-32.2 - EXHIBIT 32.2 - SPECTRUM PHARMACEUTICALS INCsppi20160331ex322.htm
EX-31.1 - EXHIBIT 31.1 - SPECTRUM PHARMACEUTICALS INCsppi20160331ex311.htm
EX-31.2 - EXHIBIT 31.2 - SPECTRUM PHARMACEUTICALS INCsppi20160331ex312.htm
10-Q - 10-Q - SPECTRUM PHARMACEUTICALS INCsppi2016033110q.htm

Exhibit 32.1
I, Rajesh C. Shrotriya, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Report of Spectrum Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents in all material respects the financial condition and results of operations of Spectrum Pharmaceuticals, Inc.
May 6, 2016
/s/ Rajesh C. Shrotriya
Rajesh C. Shrotriya, MD
Chairman and Chief Executive Officer
This certification accompanies the Report pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities and Exchange Act of 1934, or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, or, the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporated by reference.